Mereo Biopharma Group plc — Form D

Mereo Biopharma Group plc of LONDON, X0, a company, filed a Form D exempt-offering notice with the SEC on 2020-06-12. The offering totals $70.0M, of which $70.0M was reported sold. Industry: Pharmaceuticals.

Offering

Filed: 2020-06-12
Form: D
Accession: 0001719714-20-000001
Industry: Pharmaceuticals
Exemptions: 06b
Total offering: $70.0M
Amount sold: $70.0M
Minimum investment: $1
Investors: 25
Date of first sale: 2020-06-03
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-368827

Issuer

Name: Mereo Biopharma Group plc
CIK: 0001719714
Entity type: Other
Jurisdiction: UNITED KINGDOM
Address: 1 CAVENDISH PLACE, LONDON, X0, W1G 0QF
Phone: +44 333 0237 300

Officers, directors & promoters (15)

Name	Role	Location
Peter Bains	Director	London, X0
Paul Blackburn	Director	London, X0
Dr. Anders Ekblom	Director	London, X0
Dr. Peter Fellner	Director	London, X0
Richard Jones	Director	Las Vegas, NV
Kunal Kashyap	Director	London, X0
Dr. Deepa Pakianathan	Director	London, X0
Dr. Denise Scots-Knight	Director	London, X0
Michael Wyzga	Director	Boston, MA
Jill Henrich	Executive Officer	London, X0
Richard Jones	Executive Officer	Las Vegas, NV
Dr. Alastair MacKinnon	Executive Officer	London, X0
John Richard	Executive Officer	London, X0
Dr. Denise Scots-Knight	Executive Officer	London, X0
Charles Sermon	Executive Officer	London, X0

More